BACKGROUND: Worldwide, dengue is the most prevalent human arbovirus disease. Dengue infection may cause a range of clinical manifestations from self-limiting febrile illness through to a life-threatening syndrome accompanied by both bleeding and shock. Thrombocytopenia is frequently observed in mild and severe disease; however, the mechanisms involved in DENV-induced platelet activation and thrombocytopenia are incompletely understood. PATIENTS AND METHODS: Freshly isolated platelets from patients with dengue were evaluated for markers of activation, mitochondrial alteration and activation of cell death pathways. In parallel, we examined direct DENV-induced activation and apoptosis of platelets obtained from healthy subjects. RESULTS: We found that platelets from DENV-infected patients exhibited increased activation by comparison to control subjects. Moreover, platelets from DENV-infected patients exhibited classic signs of the intrinsic pathway of apoptosis that include increased surface phosphatidylserine exposure, mitochondrial depolarization and activation of caspase-9 and -3. Indeed, thrombocytopenia was shown to strongly associate with enhanced platelet activation and cell death in DENV-infected patients. Platelet activation, mitochondrial dysfunction and caspase-dependent phosphatidylserine exposure on platelets were also observed when platelets from healthy subjects were directly exposed to DENV in vitro. DENV-induced platelet activation was shown to occur through mechanisms largely dependent on DC-SIGN. CONCLUSIONS: Together our results demonstrate that platelets from patients with dengue present signs of activation, mitochondrial dysfunction and activation of the apoptosis caspase cascade, which may contribute to the development of thrombocytopenia in patients with dengue. Our results also suggest the involvement of DC-SIGN as a critical receptor in DENV-dependent platelet activation.
BACKGROUND: Worldwide, dengue is the most prevalent humanarbovirus disease. Dengue infection may cause a range of clinical manifestations from self-limiting febrile illness through to a life-threatening syndrome accompanied by both bleeding and shock. Thrombocytopenia is frequently observed in mild and severe disease; however, the mechanisms involved in DENV-induced platelet activation and thrombocytopenia are incompletely understood. PATIENTS AND METHODS: Freshly isolated platelets from patients with dengue were evaluated for markers of activation, mitochondrial alteration and activation of cell death pathways. In parallel, we examined direct DENV-induced activation and apoptosis of platelets obtained from healthy subjects. RESULTS: We found that platelets from DENV-infectedpatients exhibited increased activation by comparison to control subjects. Moreover, platelets from DENV-infectedpatients exhibited classic signs of the intrinsic pathway of apoptosis that include increased surface phosphatidylserine exposure, mitochondrial depolarization and activation of caspase-9 and -3. Indeed, thrombocytopenia was shown to strongly associate with enhanced platelet activation and cell death in DENV-infectedpatients. Platelet activation, mitochondrial dysfunction and caspase-dependent phosphatidylserine exposure on platelets were also observed when platelets from healthy subjects were directly exposed to DENV in vitro. DENV-induced platelet activation was shown to occur through mechanisms largely dependent on DC-SIGN. CONCLUSIONS: Together our results demonstrate that platelets from patients with dengue present signs of activation, mitochondrial dysfunction and activation of the apoptosis caspase cascade, which may contribute to the development of thrombocytopenia in patients with dengue. Our results also suggest the involvement of DC-SIGN as a critical receptor in DENV-dependent platelet activation.
Authors: Maria Terrese G Alonzo; Talitha Lea V Lacuesta; Efren M Dimaano; Takeshi Kurosu; Lady-Anne C Suarez; Cynthia A Mapua; Yukihiro Akeda; Ronald R Matias; David J Kuter; Shigekazu Nagata; Filipinas F Natividad; Kazunori Oishi Journal: J Infect Dis Date: 2012-03-01 Impact factor: 5.226
Authors: A S Weyrich; M R Elstad; R P McEver; T M McIntyre; K L Moore; J H Morrissey; S M Prescott; G A Zimmerman Journal: J Clin Invest Date: 1996-03-15 Impact factor: 14.808
Authors: Boonrat Tassaneetrithep; Timothy H Burgess; Angela Granelli-Piperno; Christine Trumpfheller; Jennifer Finke; Wellington Sun; Michael A Eller; Kovit Pattanapanyasat; Suttipant Sarasombath; Deborah L Birx; Ralph M Steinman; Sarah Schlesinger; Mary A Marovich Journal: J Exp Med Date: 2003-04-07 Impact factor: 14.307
Authors: Nieli Rodrigues da Costa Faria; Victor Edgar Fiestas Solorzano; Luiz José de Souza; Rita Maria Ribeiro Nogueira; Fernanda de Bruycker-Nogueira; Thaís Chouin-Carneiro; Jaqueline Bastos Santos Simões; Monique da Rocha Queiroz Lima; Luzia Maria de Oliveira Pinto; Claire Fernandes Kubelka; Manoela Heringer; Elzinandes Leal de Azeredo; Flavia Barreto Dos Santos Journal: Am J Trop Med Hyg Date: 2017-07 Impact factor: 2.345
Authors: Milka Koupenova; Olga Vitseva; Christopher R MacKay; Lea M Beaulieu; Emelia J Benjamin; Eric Mick; Evelyn A Kurt-Jones; Katya Ravid; Jane E Freedman Journal: Blood Date: 2014-04-22 Impact factor: 22.113